UniProt ID | STK25_HUMAN | |
---|---|---|
UniProt AC | O00506 | |
Protein Name | Serine/threonine-protein kinase 25 | |
Gene Name | STK25 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 426 | |
Subcellular Localization | Cytoplasm . Golgi apparatus . Localizes to the Golgi apparatus. | |
Protein Description | Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration.. | |
Protein Sequence | MAHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWKSEGHGEESSSEDSDIDGEAEDGEQGPIWTFPPTIRPSPHSKLHKGTALHSSQKPAEPVKRQPRSQCLSTLVRPVFGELKEKHKQSGGSVGALEELENAFSLAEESCPGISDKLMVHLVERVQRFSHNRNHLTSTR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Phosphorylation | RGFANQHSRVDPEEL CCCCCCCCCCCHHHH | 25.00 | 28857561 | |
22 | Ubiquitination | DPEELFTKLDRIGKG CHHHHHHHHHHHCCC | 40.84 | - | |
28 | Ubiquitination | TKLDRIGKGSFGEVY HHHHHHCCCCHHHHH | 49.35 | - | |
30 | Phosphorylation | LDRIGKGSFGEVYKG HHHHCCCCHHHHHCC | 33.30 | - | |
35 | Phosphorylation | KGSFGEVYKGIDNHT CCCHHHHHCCCCCCC | 10.13 | - | |
36 | Ubiquitination | GSFGEVYKGIDNHTK CCHHHHHCCCCCCCC | 55.34 | - | |
43 | Ubiquitination | KGIDNHTKEVVAIKI CCCCCCCCEEEEEEE | 40.75 | - | |
48 | Ubiquitination | HTKEVVAIKIIDLEE CCCEEEEEEEEEHHH | 1.91 | 21906983 | |
65 | Ubiquitination | DEIEDIQQEITVLSQ HHHHHHHHHHHHHHH | 44.38 | 21906983 | |
78 | Ubiquitination | SQCDSPYITRYFGSY HHCCCHHHHHHHHHH | 1.69 | - | |
94 | Ubiquitination | KSTKLWIIMEYLGGG HHCCEEEEEEHHCCC | 0.86 | - | |
97 | Phosphorylation | KLWIIMEYLGGGSAL CEEEEEEHHCCCCHH | 8.02 | - | |
126 | Acetylation | TILREILKGLDYLHS HHHHHHHHHHHHHHH | 64.19 | 23236377 | |
142 | Ubiquitination | RKIHRDIKAANVLLS CHHHHCHHHHHHHHC | 45.82 | 21906983 | |
155 | Ubiquitination | LSEQGDVKLADFGVA HCCCCCCCCCCEECC | 42.57 | - | |
166 | Phosphorylation | FGVAGQLTDTQIKRN EECCCCCCCCCHHHC | 29.16 | 30266825 | |
168 | Phosphorylation | VAGQLTDTQIKRNTF CCCCCCCCCHHHCCC | 27.27 | 22322096 | |
171 | Ubiquitination | QLTDTQIKRNTFVGT CCCCCCHHHCCCCCC | 29.76 | - | |
174 | Phosphorylation | DTQIKRNTFVGTPFW CCCHHHCCCCCCCCC | 24.59 | 22322096 | |
178 | Phosphorylation | KRNTFVGTPFWMAPE HHCCCCCCCCCCCHH | 15.26 | 30266825 | |
199 | Ubiquitination | YDFKADIWSLGITAI CCCCHHHHHCCEEHH | 6.51 | - | |
216 | Phosphorylation | AKGEPPNSDLHPMRV HCCCCCCCCCCCEEE | 47.53 | 23879269 | |
231 | Phosphorylation | LFLIPKNSPPTLEGQ EEEEECCCCCCCCCC | 38.08 | 23403867 | |
234 | Phosphorylation | IPKNSPPTLEGQHSK EECCCCCCCCCCCCC | 40.60 | 23186163 | |
240 | Phosphorylation | PTLEGQHSKPFKEFV CCCCCCCCCCHHHHH | 33.85 | 23403867 | |
241 | Ubiquitination | TLEGQHSKPFKEFVE CCCCCCCCCHHHHHH | 52.96 | - | |
253 | Ubiquitination | FVEACLNKDPRFRPT HHHHHHCCCCCCCCC | 57.04 | - | |
262 | Ubiquitination | PRFRPTAKELLKHKF CCCCCCHHHHHHCCH | 51.91 | - | |
276 | Ubiquitination | FITRYTKKTSFLTEL HHHHCCCHHHHHHHH | 41.42 | - | |
277 | Phosphorylation | ITRYTKKTSFLTELI HHHCCCHHHHHHHHH | 26.68 | 28450419 | |
278 | Phosphorylation | TRYTKKTSFLTELID HHCCCHHHHHHHHHH | 27.43 | 28450419 | |
281 | Phosphorylation | TKKTSFLTELIDRYK CCHHHHHHHHHHHHH | 27.08 | 28450419 | |
335 | Ubiquitination | SPHSKLHKGTALHSS CCCCCCCCCCCCCCC | 69.28 | - | |
337 | Phosphorylation | HSKLHKGTALHSSQK CCCCCCCCCCCCCCC | 30.74 | 23312004 | |
341 | Phosphorylation | HKGTALHSSQKPAEP CCCCCCCCCCCCCCC | 35.00 | 28555341 | |
342 | Phosphorylation | KGTALHSSQKPAEPV CCCCCCCCCCCCCCC | 31.32 | 28857561 | |
350 | Acetylation | QKPAEPVKRQPRSQC CCCCCCCCCCCHHHH | 56.91 | 25953088 | |
360 | Phosphorylation | PRSQCLSTLVRPVFG CHHHHHHHHHHHHHH | 19.14 | - | |
376 | Phosphorylation | LKEKHKQSGGSVGAL HHHHHHHCCCCHHHH | 50.34 | 28102081 | |
379 | Phosphorylation | KHKQSGGSVGALEEL HHHHCCCCHHHHHHH | 22.39 | 28348404 | |
416 | Phosphorylation | VERVQRFSHNRNHLT HHHHHHHHHCCCCCC | 23.26 | 26074081 | |
423 | Phosphorylation | SHNRNHLTSTR---- HHCCCCCCCCC---- | 22.09 | 26074081 | |
424 | Phosphorylation | HNRNHLTSTR----- HCCCCCCCCC----- | 28.66 | 26074081 | |
425 | Phosphorylation | NRNHLTSTR------ CCCCCCCCC------ | 34.85 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
174 | T | Phosphorylation | Kinase | STK25 | O00506 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STK25_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STK25_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-168 AND SER-342, ANDMASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-168 AND THR-174, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-168, AND MASSSPECTROMETRY. | |
"YSK1 is activated by the Golgi matrix protein GM130 and plays a rolein cell migration through its substrate 14-3-3zeta."; Preisinger C., Short B., De Corte V., Bruyneel E., Haas A.,Kopajtich R., Gettemans J., Barr F.A.; J. Cell Biol. 164:1009-1020(2004). Cited for: FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT THR-174, SUBCELLULARLOCATION, INTERACTION WITH GOLGA2, AND MUTAGENESIS OF LYS-49 ANDASP-158. |